Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,962 | -16,386 | -8,570 | -3,661 | -19,445 |
| Depreciation Amortization | 252 | 194 | 127 | 47 | 256 |
| Accounts receivable | N/A | -9 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,066 | 2,411 | 1,774 | 586 | 179 |
| Other Working Capital | 7,131 | 5,049 | 3,116 | 273 | 966 |
| Other Operating Activity | -5,754 | -2,768 | -2,285 | -925 | 1,936 |
| Operating Cash Flow | $-21,267 | $-11,509 | $-5,838 | $-3,680 | $-16,108 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -294 | -231 | N/A | N/A | 7,359 |
| PPE Investments | 47 | -10 | 35 | 29 | 3,814 |
| Purchase Of Investment | N/A | -377 | -712 | -712 | N/A |
| Sale Of Investment | N/A | N/A | 598 | 598 | N/A |
| Purchase Sale Intangibles | -585 | N/A | -203 | 7 | -185 |
| Other Investing Activity | -585 | 0 | -203 | 7 | -185 |
| Investing Cash Flow | $-832 | $-618 | $-282 | $-78 | $10,988 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 485 | 338 | 105 | 100 | 80 |
| Financing Cash Flow | $485 | $338 | $105 | $100 | $80 |
| Beginning Cash Position | 27,053 | 27,053 | 27,053 | 27,053 | 32,093 |
| End Cash Position | 5,439 | 15,264 | 21,038 | 23,395 | 27,053 |
| Net Cash Flow | $-21,614 | $-11,789 | $-6,015 | $-3,658 | $-5,040 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,267 | -11,509 | -5,838 | -3,680 | -16,108 |
| Capital Expenditure | N/A | -10 | N/A | N/A | -86 |
| Free Cash Flow | -21,267 | -11,519 | -5,838 | -3,680 | -16,194 |